Table 1.
RASTAVI Study expected recruitment
| Centre | City | Country | Expected number of patients recruited (2 years) |
| Hospital Clínico Universitario de Valladolid (coordinating centre) |
Valladolid | Spain | 50 |
| Hospital General Universitario Gregorio Marañón | Madrid | Spain | 50 |
| Hospital Universitario Puerta de Hierro | Madrid | Spain | 35 |
| Hospital Universitario Virgen de la Victoria | Málaga | Spain | 50 |
| Hospital Universitario Clínico San Carlos | Madrid | Spain | 50 |
| Hospital Clínic de Barcelona | Barcelona | Spain | 35 |
| Hospital Universitari Vall d’Hebron | Barcelona | Spain | 35 |
| Hospital Universitario de Vigo | Vigo | Spain | 35 |
RASTAVI, renin-angiotensin system blockade after transcatheter aortic valve implantation.